H1N1 News and Research

RSS
Novel influenza A (H1N1) is a new flu virus of swine origin that was first detected in Mexico and the United States in March and April, 2009. The first novel H1N1 patient in the United States was confirmed by laboratory testing at CDC on April 15, 2009. The second patient was confirmed on April 17, 2009. It was quickly determined that the virus was spreading from person-to-person. On April 22, CDC activated its Emergency Operations Center to better coordinate the public health response. On April 26, 2009, the United States Government declared a public health emergency.

It’s thought that novel influenza A (H1N1) flu spreads in the same way that regular seasonal influenza viruses spread; mainly through the coughs and sneezes of people who are sick with the virus.
Baxter International's global sales for first-quarter advances by 11% to $3.1 billion

Baxter International's global sales for first-quarter advances by 11% to $3.1 billion

Swine flu vaccine blues

Swine flu vaccine blues

H1N1 flu epidemic has lessons to offer health care providers: Anesthesia Progress

H1N1 flu epidemic has lessons to offer health care providers: Anesthesia Progress

AFP reflects on WHO's response to H1N1

AFP reflects on WHO's response to H1N1

Test shows efficacy of avian antibodies against H5N1 and H1N1 influenza in mice

Test shows efficacy of avian antibodies against H5N1 and H1N1 influenza in mice

Pregnant women face increased risk of death from H1N1; early antiviral treatment associated with fewer complications

Pregnant women face increased risk of death from H1N1; early antiviral treatment associated with fewer complications

UnitedHealth Group's consolidated first-quarter 2010 revenues increase 5% to $23.2 billion

UnitedHealth Group's consolidated first-quarter 2010 revenues increase 5% to $23.2 billion

Avian flu's endurance in 5 countries poses global threat to human health, FAO official says

Avian flu's endurance in 5 countries poses global threat to human health, FAO official says

Pharmacists Mutual Insurance selects Interactive Intelligence's CIC to support employees

Pharmacists Mutual Insurance selects Interactive Intelligence's CIC to support employees

NVIC participates in NVAC-sponsored meeting to discuss the U.S. vaccine safety system

NVIC participates in NVAC-sponsored meeting to discuss the U.S. vaccine safety system

GeoViz methods help users visualize the pattern of how disease spreads

GeoViz methods help users visualize the pattern of how disease spreads

Idaho Technology receives USASMDC contract to develop flu tests for military personnel

Idaho Technology receives USASMDC contract to develop flu tests for military personnel

First meeting of WHO H1N1 response probe concludes

First meeting of WHO H1N1 response probe concludes

SJHS-HC tracks potential influenza cases using SafetySurveillor solution

SJHS-HC tracks potential influenza cases using SafetySurveillor solution

Study finds variation in H1N1 infection risks and antibody levels: JAMA

Study finds variation in H1N1 infection risks and antibody levels: JAMA

WHO official says agency struggled to find 'right tempo' for release of H1N1 information

WHO official says agency struggled to find 'right tempo' for release of H1N1 information

Opinions: Health and living conditions; H1N1, one year later; global water shortages

Opinions: Health and living conditions; H1N1, one year later; global water shortages

GBS cases reduce following 2009 H1N1 vaccination: Research study

GBS cases reduce following 2009 H1N1 vaccination: Research study

WHO discusses shortcomings of its H1N1 response

WHO discusses shortcomings of its H1N1 response

Swine flu shots important before peak season, say experts

Swine flu shots important before peak season, say experts

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.